Rover Group Inc - Ordinary Shares (ROVR) 10-Q 9 May 23 2023 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2023	May 05, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	001-39774
Entity Registrant Name	Rover Group, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	85-3147201
Entity Address, Address Line One	720 Olive Way,
Entity Address, Address Line Two	19th Floor
Entity Address, City or Town	Seattle
Entity Address, State or Province	WA
Entity Address, Postal Zip Code	98101
City Area Code	888
Local Phone Number	453-7889
Title of 12(b) Security	Class A Common Stock, par value $0.0001 per share
Trading Symbol	ROVR
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	true
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		184,220,211
Entity Central Index Key	0001826018
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 76,120	$ 58,875
Short-term investments	176,427	191,347
Accounts receivable, net	70,523	53,181
Notes receivable from related parties	1,810	1,810
Prepaid expenses and other current assets	11,929	6,829
Total current assets	336,809	312,042
Property and equipment, net	19,409	19,518
Operating lease right-of-use assets	18,324	18,871
Intangible assets, net	6,370	6,865
Goodwill	36,915	36,915
Deferred tax asset, net	1,378	1,306
Long-term investments	12,118	22,463
Other noncurrent assets	366	281
Total assets	431,689	418,261
Current liabilities
Accounts payable	4,823	5,354
Accrued compensation and related expenses	4,032	6,644
Accrued expenses and other current liabilities	23,858	22,694
Deferred revenue	12,926	5,544
Pet parent deposits	51,356	40,783
Pet care provider liabilities	2,978	3,319
Operating lease liabilities, current portion	2,478	2,727
Total current liabilities	102,451	87,065
Operating lease liabilities, net of current portion	21,470	22,208
Other noncurrent liabilities	858	714
Total liabilities	124,779	109,987
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.0001 par value, 10,000 shares authorized as of March 31, 2023 and December 31, 2022; no shares issued and outstanding as of March 31, 2023 and December 31, 2022	0	0
Class A common stock, $0.0001 par value, 990,000 shares authorized as of March 31, 2023 and December 31, 2022; 185,241 and 184,526 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively	19	18
Additional paid-in capital	657,355	651,659
Accumulated other comprehensive loss	(447)	(1,098)
Accumulated deficit	(350,017)	(342,305)
Total stockholders’ equity	306,910	308,274
Total liabilities and stockholders’ equity	$ 431,689	$ 418,261

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2023	Dec. 31, 2022
Stockholders’ equity:
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	990,000,000	990,000,000
Common stock, shares issued (in shares)	185,241,000	184,526,000
Common stock, shares outstanding (in shares)	185,241,000	184,526,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Revenue	$ 41,120	$ 27,824
Costs and expenses:
Cost of revenue (exclusive of depreciation and amortization shown separately below)	10,780	7,848
Operations and support	7,029	5,355
Marketing	9,338	7,331
Product development	7,297	6,633
General and administrative	12,362	11,540
Depreciation and amortization	1,478	1,696
Total costs and expenses	48,284	40,403
Loss from operations	(7,164)	(12,579)
Other income (expense), net:
Interest income	2,423	139
Interest expense	(18)	(18)
Change in fair value of other investments	314	0
Change in fair value of derivative warrant liabilities	0	4,579
Other income (expense), net	104	(256)
Total other income (expense), net	2,823	4,444
Loss before income taxes and equity method investments	(4,341)	(8,135)
Provision for income taxes	(1)	(11)
Loss from equity method investments	(314)	0
Net loss	$ (4,656)	$ (8,146)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.03)	$ (0.05)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.03)	$ (0.05)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	184,365	179,671
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	184,365	179,671

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (4,656)	$ (8,146)
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	57	(61)
Unrealized gain (loss) on available-for-sale debt securities	594	(410)
Other comprehensive income (loss), net of tax	651	(471)
Comprehensive loss	$ (4,005)	$ (8,617)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders’ Equity - USD ($) shares in Thousands, $ in Thousands	Total	Warrant [Member]	Common Stock	Common Stock Warrant [Member]	Additional Paid-In Capital	Additional Paid-In Capital Warrant [Member]	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021			177,342
Beginning balance at Dec. 31, 2021	$ 292,592		$ 18		$ 612,680		$ 220	$ (320,326)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Reclassification of derivative warrant liability and issuance of common stock from exercises of warrants (in shares)				2,046
Reclassification of derivative warrant liability and issuance of common stock from exercises of warrants		$ 15,356				$ 15,356
Exercise of stock options and issuance of common stock (in shares)			2,242
Issuance of common stock upon exercise of stock options	2,005				2,005
Issuance of common stock upon release of restricted stock units (in shares)			200
Issuance of common stock upon release of restricted stock units	348				348
Taxes paid related to settlement of equity awards	(393)				(393)
Stock-based compensation	4,447				4,447
Foreign currency translation adjustments	(61)						(61)
Unrealized gain (loss) on available-for-sale debt securities	(410)						(410)
Net loss	(8,146)							(8,146)
Ending balance (in shares) at Mar. 31, 2022			181,830
Beginning balance at Mar. 31, 2022	$ 305,738		$ 18		634,443		(251)	(328,472)
Beginning balance (in shares) at Dec. 31, 2022	184,526		184,526
Beginning balance at Dec. 31, 2022	$ 308,274		$ 18		651,659		(1,098)	(342,305)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options and issuance of common stock (in shares)	1,039		1,039
Issuance of common stock upon exercise of stock options	$ 1,847		$ 1		1,846
Issuance of common stock upon release of restricted stock units (in shares)			308
Taxes paid related to settlement of equity awards	(1,129)				(1,129)
Repurchase and retirement of common stock (in shares)			(632)
Repurchase and retirement of common stock	(3,056)							(3,056)
Stock-based compensation	4,979				4,979
Foreign currency translation adjustments	57						57
Unrealized gain (loss) on available-for-sale debt securities	594						594
Net loss	$ (4,656)							(4,656)
Ending balance (in shares) at Mar. 31, 2023	185,241		185,241
Beginning balance at Mar. 31, 2023	$ 306,910		$ 19		$ 657,355		$ (447)	$ (350,017)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
OPERATING ACTIVITIES
Net loss	$ (4,656)	$ (8,146)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	4,505	4,310
Depreciation and amortization	3,234	3,428
Non-cash operating lease costs	547	588
Change in fair value of other investments	(314)	0
Change in fair value of derivative warrant liabilities	0	(4,579)
Net (accretion) amortization of investment (discounts) premiums	(1,406)	23
Deferred income taxes	(44)	0
Loss on disposal of property and equipment	53	7
Loss from equity method investments	314	0
Changes in operating assets and liabilities:
Accounts receivable	(17,342)	(193)
Prepaid expenses and other current assets	(5,095)	(2,166)
Other noncurrent assets	(86)	52
Accounts payable	(535)	(515)
Accrued expenses and other current liabilities	(1,460)	(2,050)
Deferred revenue and pet parent deposits	17,956	15,097
Pet care provider liabilities	(341)	(6,274)
Operating lease liabilities	(987)	(676)
Other noncurrent liabilities	144	(18)
Net cash used in operating activities	(5,513)	(1,112)
INVESTING ACTIVITIES
Purchases of property and equipment	(181)	(297)
Capitalization of internal-use software	(2,022)	(1,732)
Purchases of available-for-sale securities	(48,549)	(123,642)
Maturities of available-for-sale securities	75,814	0
Net cash provided by (used in) investing activities	25,062	(125,671)
FINANCING ACTIVITIES
Proceeds from exercise of stock options and issuance of common stock	1,846	2,353
Redemption of stock warrants	0	(7)
Repurchases of common stock	(3,056)	0
Taxes paid related to settlement of equity awards	(1,129)	(393)
Net cash (used in) provided by financing activities	(2,339)	1,953
Effect of exchange rate changes on cash and cash equivalents	35	(24)
Net increase (decrease) in cash and cash equivalents	17,245	(124,854)
Cash and cash equivalents, beginning of period	58,875	278,904
Cash and cash equivalents, end of period	76,120	154,050
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for income taxes	15	0
Cash paid for interest	0	0
NON-CASH INVESTING AND FINANCING ACTIVITIES
Purchase of property and equipment in accounts payable and accrued liabilities	3	0
Reclassification of certain derivative warrant liabilities to equity upon exercise	0	15,356
Stock-based compensation capitalized to internal-use software	$ 475	$ 0

Organization and Description of

Organization and Description of Business	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Organization and Description of Business Rover Group, Inc. and its wholly owned subsidiaries (collectively “Rover” or the “Company”) is headquartered in Seattle, Washington, with U.S. offices in Spokane, Washington and internationally in Barcelona, Spain. The Company also has coworking office space in San Antonio, Texas. The Company provides an online marketplace and other related tools, support and services that pet parents and pet care providers can use to find, communicate with, and interact with each other. On July 30, 2021 (the “Closing Date” or “Closing”), Nebula Caravel Acquisition Corp. (“Caravel”) consummated the previously announced merger pursuant to a Business Combination Agreement and Plan of Merger, dated February 10, 2021 (the “Business Combination Agreement”), by and between Caravel, Fetch Merger Sub, Inc., a wholly owned subsidiary of Caravel (“Merger Sub”), and A Place for Rover, Inc. (hereinafter referred to as “Legacy Rover”). Pursuant to the terms of the Business Combination Agreement, Merger Sub merged with and into Legacy Rover, with Legacy Rover continuing as the surviving entity and as a wholly owned subsidiary of Caravel (together with the other transactions described in the Business Combination Agreement, the “Merger”). On the Closing Date, Caravel changed its name from Nebula Caravel Acquisition Corp. to “Rover Group, Inc.” Impact of COVID-19 and Other Seasonal Illnesses The ongoing COVID-19 pandemic and other seasonal illnesses continue to impact communities globally, including in the markets the Company serves, which in turn impacts its business. Of particular importance is the pandemic’s impact on travel and the return of workers to their offices, as well as the increasing adoption of remote and hybrid working arrangements. These factors could result in fewer bookings and higher than average cancellation rates if the pandemic or permanent changes in working arrangements depresses travel or office attendance. The impact of the COVID-19 pandemic, including the resulting complications from COVID-19, and non-COVID illnesses that may result from reduced immunity caused by social distancing during the pandemic, may continue to affect results in 2023 and beyond. The extent to which the pandemic will continue to impact the Company’s business, operating results and financial position will depend on future developments, which are highly uncertain, difficult to predict and beyond our knowledge and control. These may include, but are not limited to, the duration and spread of the pandemic, its severity, new variants and sub-variants, other health-related events, actions to contain the virus or treat its impact, the extent of the business disruption and financial impacts, and the magnitude and timing of such factors as economic and operating conditions. Liquidity As of March 31, 2023, the balance of cash and cash equivalents, short term investments, and long term investments was $76.1 million, $176.4 million, and $12.1 million, respectively. The Company has incurred losses from operations and had an accumulated deficit of $350.0 million as of March 31, 2023. The Company has primarily funded its operations with proceeds from the issuance of redeemable convertible preferred stock, common stock and other equity transactions, proceeds from the Merger, and debt borrowings. As the Company continues to invest in expansion activities, management expects operating losses could continue in the foreseeable future. Management believes that the Company’s current cash and cash equivalents and investments will be sufficient to fund its operations for at least the next 12 months from the issuance of these condensed consolidated financial statements. The Company’s assessment of the period of time through which its financial resources will be adequate to support its operations is a forward-looking statement and involves risks and uncertainties. The Company’s actual results could vary as a result of its near and long-term future capital requirements that will depend on many factors. The Company has based its estimates on assumptions that may prove to be wrong, and it could use its available capital resources sooner than it currently expects. The Company may be required to seek additional equity or debt financing. If additional financing is required from outside sources, the Company may not be able to raise it on acceptable terms or at all. If the Company is unable to raise additional capital when desired, or if it cannot expand its operations or otherwise capitalize on its business opportunities because it lacks sufficient capital, its business, operating results, and financial condition would be adversely affected.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Principles of Consolidation and Basis of Presentation The unaudited condensed consolidated financial statements and accompanying notes include the accounts of the Company and its wholly owned subsidiaries, after elimination of all intercompany balances and transactions. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and the requirements of the U.S. Securities and Exchange Commission (the “SEC”) for interim financial information. Certain information and disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. Accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto for the year ended December 31, 2022. The information as of December 31, 2022 included in the condensed consolidated balance sheets was derived from those audited financial statements. The unaudited condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for the fair presentation of the Company’s financial information for the interim periods presented. The unaudited condensed consolidated results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any other future annual or interim period. Reclassifications Certain amounts previously presented for prior periods have been reclassified to conform to current presentation. These reclassifications did not affect assets, liabilities, net income, cash flows or equity for the periods presented. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated balance sheets and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions, include, but are not limited to, the capitalization and estimated useful life of the Company’s internal-use software development costs, the assumptions used in the valuation of leases, legal contingencies, and stock-based compensation expense. These estimates and assumptions are based on information available as of the date of the condensed consolidated financial statements; therefore, actual results could differ from management’s estimates. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions. Segment Information The Company has one operating segment and one reportable segment. As the Company’s chief operating decision maker, the chief executive officer, reviews financial information on a consolidated basis for purposes of allocating resources and evaluating financial performance. Substantially all long-lived assets are located in the United States and substantially all revenue is attributed to fees from pet parents and pet care providers based in the United States. Foreign Currencies Foreign currency transaction gains and losses are a result of the effect of exchange rate changes on transactions denominated in currencies other than the functional currency. Gains and losses on those foreign currency transactions are included in determining net loss for the period of exchange and are recorded in other expense, net in the condensed consolidated statements of operations. The net effect of foreign currency gains and losses was not material during the three months ended March 31, 2023 and 2022. Certain Significant Risks and Uncertainties The Company is subject to certain risks and challenges associated with other companies at a similar stage of development, including risks associated with: dependence on key personnel; marketing; adaptation to changing market dynamics and customer preferences; and potential competition including from larger companies that may have greater name recognition, longer operating histories, more and better established customer relationships and greater resources than the Company. The Company’s ability to provide a reliable platform largely depends on the efficient and consistent operation of its technology information systems and those of its third-party service providers. Any significant interruptions could harm the Company’s business and reputation and result in a loss of business. Further, there has been evidence that the Company has been the subject of cyber-attacks, and it is possible that it will be subject to similar attacks in the future. These attacks may be primarily aimed at interrupting the Company’s business, exposing it to financial losses, or exploiting information security vulnerabilities. To management’s knowledge, no prior attacks or breaches have, individually, or in the aggregate, resulted in any material liability to the Company, any material damage to the Company’s reputation, or any material disruption to the Company’s business. Concentrations of Credit Risk Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash, investments and accounts receivable. The Company maintains cash balances that may exceed the insured limits set by the Federal Deposit Insurance Corporation. The Company has not experienced any losses on its deposits of cash and cash equivalents. The Company reduces credit risk by placing cash and investment balances with major financial institutions that management assesses to be of high-credit quality and also limits purchases of debt securities to investment-grade securities. The Company regularly evaluates the credit rating for issuers of government and corporate debt securities that it holds and other non-financial third party institutions. For the three months ended March 31, 2023 and 2022, no individual pet care provider, pet parent, or affiliate represented 10% or more of the Company’s revenue. As of March 31, 2023 and December 31, 2022, accounts receivable was $70.5 million and $53.2 million, respectively, and was inclusive of $68.2 million and $51.1 million, respectively, which was due from payment processors who collected payment from pet parents on behalf of the Company. As of March 31, 2023 and December 31, 2022, the accounts receivable balance was also inclusive of $1.8 million and $1.4 million, respectively, which was due from arrangements with third parties, in which these third parties reimburse the Company for credits issued to pet parents. The Company's receivables are short-term in nature and the Company’s historical experience of losses has not been significant. Revenue Recognition Marketplace Platform Revenue The Company operates an online marketplace that provides a platform for pet parents and pet care providers to communicate and arrange for pet care services. The Company derives its revenue principally from pet parents’ and pet care providers’ use of the Company’s platform and related services that enable pet care providers to offer, book, and fulfill pet care services. The Company enters into its standard terms of service with pet care providers and pet parents who wish to use the Company’s platform. The terms of service define the rights and responsibilities of pet care providers and pet parents when using the Company’s platform as well as general payment terms. The Company charges a fixed percentage service fee for each arrangement of pet care services between the pet parent and the pet care provider on the Company’s platform (a booking). The fixed percentage service fees generally are established at the time a pet parent or pet care provider joined the platform and do not vary based on the volume of transactions. A booking defines the explicit fee from which the Company earns its fixed percentage service fee. The creation of a booking combined with the terms of service establish enforceable rights and obligations for the transaction. A contract exists between the pet care provider and the Company upon the creation of a booking and after the pet care providers’ cancellation period has lapsed. Pet parents are considered the Company’s customers to the extent that they pay a fixed percentage fee, generally up to a fixed dollar amount to the Company for the booking. Similarly, a contract exists between the pet parent and the Company upon the creation of a booking and after the pet care providers’ stated cancellation period has lapsed. Pet parents pay for services at the time of booking. The Company considers the facilitation of the connection between pet care provider and pet parent to be the promise in the contracts. This is consistent with the terms of service, as well as the substance of what a pet care provider or pet parent is expecting from the use of the Company’s platform. While customers have access to the use of the platform, customer support, and other activities, these activities are not considered distinct from each other in the context of the overall arrangement, which is the facilitation of a connection between a pet care provider and a pet parent. As such, the Company has determined that its sole performance obligation is to facilitate a connection between pet care providers and pet parents through its platform. The Company’s performance obligation is satisfied at a point-in-time when the connection has been completed, which is when the pet care provider and pet parent have completed a booking, any related cancellation period has lapsed, and the related underlying pet care services have begun. The Company derives revenue from pet care providers and pet parents primarily in the United States, as well as Canada, the United Kingdom and Western Europe. Judgment is required in determining whether the Company is the principal or agent in transactions with pet care providers and pet parents. The Company evaluates the presentation of revenue on a gross or net basis based on whether it controls the service provided to the pet parent and is therefore the principal, or the Company arranges for other parties to provide the service to the pet parent and is therefore the agent. The Company has concluded it is the agent in transactions with pet care providers and pet parents because, among other factors, it is not responsible for the delivery of pet care services provided by the pet care provider to the pet parent. Accordingly, the Company recognizes revenue on a net basis, representing the fee the Company expects to receive in exchange for providing access to the Company’s platform to pet care providers and pet parents. The Company has no significant financing components in its contracts with customers. The Company recognizes revenue net of any sales tax paid related to its revenue transactions. Provider Onboarding Revenue The Company earns revenue from non-refundable provider onboarding fees by completing quality assurance reviews of new pet care provider profiles including obtaining background checks, which are performed by a third party. Pet care providers pay the onboarding fee at the time of sign up. The Company recognizes revenue related to provider onboarding services at a point-in-time upon satisfaction of the related performance obligation, determined to be the completion of the quality assurance review of the pet care provider’s profile including a background check. The Company is considered to be a principal in these transactions and recognizes revenue on a gross basis. Costs associated with performing the pet care provider onboarding review are recognized in cost of revenue (exclusive of depreciation and amortization shown separately). Payments to Customers From time to time, the Company makes payments to pet parents and pet care providers as part of its marketing promotions, incentive programs and refund activities. Marketing Promotions and Incentive Programs The Company encourages the use of its platform and attracts new customers through its marketing promotions and incentive programs. The Company uses marketing promotions in tandem with sales and marketing spend to attract new pet parents to its platform. Promotions offered to pet parents in the form of credits, coupons or discounts are recorded as a reduction of revenue or marketing expense. The Company offers referral credits to its existing pet parents or pet care providers for referrals of new pet parents or pet care providers. These referral credits are paid in exchange for a distinct marketing service and therefore the portion of these credits that is equal to or less than the cost of acquiring a new pet parent or pet care provider are accounted for as a customer acquisition cost. These new customer acquisition costs are expensed as incurred and reflected as marketing expenses in the Company’s condensed consolidated statements of operations. The portion of these credits in excess of the fair value of acquiring a new pet parent or pet care provider is accounted for as a reduction of revenue. On occasion, the Company offers promotional discounts to existing pet parents. The Company records incentives provided to existing pet parents as a promotion and reduces revenue on the date that the corresponding revenue transaction is recorded. Refunds In certain instances, the Company issues refunds to pet parents as part of its customer support activities for customer satisfaction matters in the form of credits to be applied toward a future booking. The Company accounts for such refunds as variable consideration and therefore records the amount of each refund or credit issued as a reduction of revenue. Pet Parent Deposits and Pet Care Provider Liabilities The Company records payments received from pet parents, excluding the revenue portion due to the Company, in advance of the related services being provided as pet parent deposits. As the related performance obligations are satisfied, these amounts are settled through our payment processor and derecognized. In addition, we hold pet care provider liabilities relating to stays completed prior to the implementation of our current payment processor and related systems where payment has not yet been requested by the pet care provider. The Company is subject to compliance with escheat laws applicable by jurisdiction where pet care providers do not claim the amounts owed to them for services rendered. Rover Guarantee In connection with services provided to facilitate the connections between pet care provider and pet parent, the Company provides a contractual guarantee to reimburse pet parents or pet care providers for certain expenses arising from injuries or other damages incurred during a service booked through the Company’s platform, subject to specified conditions (the “Rover Guarantee”). The Company’s obligation under the Rover Guarantee is accounted for in accordance with Accounting Standards Codification Topic 460, Guarantees . As a result, the Company estimates the fair value of the liability incurred in connection with providing the Rover Guarantee and records such amounts in accrued expenses and other current liabilities within the Company’s condensed consolidated balance sheets. Marketing Advertising expenses were $7.0 million during the three months ended March 31, 2023, and $5.3 million during the three months ended March 31, 2022. Recently Adopted Accounting Pronouncements The Company is provided the option to adopt new or revised accounting guidance as an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) either (1) within the same periods as those otherwise applicable to public business entities, or (2) within the same time periods as private companies, including early adoption when permissible. The Company has elected to adopt new or revised accounting guidance within the same time period as public business entities, as indicated below. In March 2022, the FASB issued ASU No. 2022-02 Financial Instruments—Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures. The amendment in this ASU provides an update to: (1) troubled debt restructurings guidance in Subtopic 310-40 and enhances disclosure requirements for certain loan refinancings and restructurings; and (2) requires public entities to disclose current period gross write-offs by year of origination for financing receivables and net investments in leases. The guidance is effective for the Company for the year beginning after December 15, 2022. The Company adopted this standard on January 1, 2023 using the prospective transition method. The adoption of the new standard did not have a material impact on the Company’s condensed consolidated financial statements. Recently Issued Accounting Pronouncements In June 2022, the FASB issued ASU No. 2022-03 Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restriction. The amendment in this ASU clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. This amendment also requires public entities to add certain disclosures for equity securities subject to contractual sale restrictions. The guidance is effective for the Company for the year beginning after December 15, 2023. The Company will adopt this standard on January 1, 2024 using the prospective transition method. We do not expect the adoption of the new standard to have a material impact on the Company’s condensed consolidated financial statements but will continue to evaluate the new standard in future accounting periods.

Revenue Recognition

Revenue Recognition	3 Months Ended
	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Contract Balances Contract liability balances on the Company’s condensed consolidated balance sheets consist of deferred revenue for amounts collected upon the completion of a booking. Deferred revenue is limited to the amount which the Company expects to recognize as revenue and the amounts expected to be paid out to pet care providers are separately presented as customer deposits on the Company’s condensed consolidated balance sheets, as those amounts will not result in revenue recognized. The deferred revenue balance is reduced by the amount of credits, coupons, or discounts to the extent that they are expected to reduce the revenue recognized upon satisfaction of the performance obligation. Substantially all of the deferred revenue as of March 31, 2023 relates to bookings that begin within the next twelve months, at which time revenue will be recognized, unless the booking is canceled during the pet care provider’s cancellation period. The changes in the Company’s deferred revenue balances were as follows (in thousands): Balance at December 31, 2022 $ 5,544 Bookings and other 46,630 Revenue recognized (39,248) Balance at March 31, 2023 $ 12,926

Investments

Investments	3 Months Ended
	Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Investments	Investments The Company’s investments include available-for-sale investments and convertible notes. Available-for-sale investments consist of marketable securities that are accounted for at fair value. Premiums and discounts paid on securities at the time of purchase are amortized over the period of maturity. The amortized cost and fair value of the investments and unrealized gains and losses were as follows (in thousands): March 31, 2023 Amortized Costs Gross Unrealized Gains Gross Unrealized Losses Fair Value Marketable securities: Commercial paper $ 51,327 $ — $ (35) $ 51,292 Corporate securities 19,841 — (84) 19,757 US Government securities 103,780 9 (391) 103,398 Asset-backed securities 7,554 — (33) 7,521 Agency bonds 6,560 17 — 6,577 Total marketable securities 189,062 26 (543) 188,545 Other investments: Convertible notes 1,810 — — 1,810 Total other investments 1,810 — — 1,810 Total investments $ 190,872 $ 26 $ (543) $ 190,355 December 31, 2022 Amortized Costs Gross Unrealized Gains Gross Unrealized Losses Fair Value Marketable securities: Commercial paper $ 54,851 $ — $ (51) $ 54,800 Corporate securities 38,260 — (220) 38,040 US Government securities 108,551 — (792) 107,759 Asset-backed securities 8,269 — (35) 8,234 Agency bonds 4,989 — (12) 4,977 Total marketable securities 214,920 — (1,110) 213,810 Other investments: Convertible notes 1,810 — — 1,810 Total other investments 1,810 — — 1,810 Total investments $ 216,730 $ — $ (1,110) $ 215,620 The contractual maturity of the available-for-sale investments were as follows (in thousands): March 31, 2023 Within 1 year 1 to 5 years More than 5 years Total Marketable securities: Commercial paper $ 51,292 $ — $ — $ 51,292 Corporate securities 17,553 2,204 — 19,757 US Government securities 101,005 2,393 — 103,398 Asset-backed securities — 7,521 — 7,521 Agency bonds 6,577 — — 6,577 Total marketable securities 176,427 12,118 — 188,545 Other investments: Convertible notes 1,810 — — 1,810 Total other investments 1,810 — — 1,810 Total investments $ 178,237 $ 12,118 $ — $ 190,355 December 31, 2022 Within 1 year 1 to 5 years More than 5 years Total Marketable securities: Commercial paper $ 54,800 $ — $ — $ 54,800 Corporate securities 32,767 5,273 — 38,040 US Government securities 101,289 6,470 — 107,759 Asset-backed securities — 8,234 — 8,234 Agency bonds 2,491 2,486 — 4,977 Total marketable securities 191,347 22,463 — 213,810 Other investments: Convertible notes 1,810 — — 1,810 Total other investments 1,810 — — 1,810 Total investments $ 193,157 $ 22,463 $ — $ 215,620 The Company believes there were no fundamental issues such as credit losses or other factors with respect to any of its available-for-sale securities. The unrealized losses on investments in fixed-maturity securities were caused primarily by interest rate changes. It is expected that the securities would not be settled at a price less than par value of the investments. Because the declines in fair value are attributable to changes in interest rates or market conditions and not credit quality, and because the Company has the ability to hold its available-for-sale investments until a market price recovery or maturity, the Company has not recognized any credit loss reserves as of March 31, 2023 and December 31, 2022. Other Investments Convertible Notes (Related Party Transaction) In July 2022, the Company entered into transaction agreements with Pioneer Square Labs (“PSL”) and entities affiliated with PSL, a start-up studio and venture capital fund of which one of the Company’s directors, Greg Gottesman, is a managing director and co-founder, to co-invest in an early-stage company that provides a service for pet parents that is complementary to the Company’s current offerings (the “Investee”). The Company contributed intellectual property in the form of a nonexclusive license agreement in exchange for 5,000,000 shares of common stock, which represents 28% of the Investee’s diluted outstanding equity as of March 31, 2023. The Company accounts for this investment under the equity method as it has significant influence over the Investee but does not hold a controlling financial interest. In July 2022, in conjunction with the agreement, the Company made an initial investment of $1.0 million in the Investee in the form of a convertible note, which had a maturity date of July 2023. Subsequently, the Company invested an additional $0.3 million and $0.5 million in September 2022 and November 2022, respectively. As of November 2022, all investments in the form of convertible notes were amended to mature in November 2023. The convertible notes accrue interest at a rate of 5% per year and are payable upon the maturity dates. The Investee may not prepay the convertible notes. If the Investee raises funds from parties other than existing stockholders of the Investee prior to the maturity dates of the convertible notes, then the Company will receive the full value of the convertible notes, including all accrued and unpaid interest, in the form of preferred stock in the Investee. The Company has elected to measure these convertible notes at fair value with changes in fair value reported in earnings (see Note 5—Fair Value for more information). PSL and the Company have equivalent minority ownership positions in the Investee, and have customary rights afforded to investors in venture-backed companies. PSL has been, and will continue to be, reimbursed for certain start-up and formation costs by the entity and will provide, and be compensated for, certain services to the entity for a period of time after formation. For the three months ended March 31, 2023, the amount reimbursed to PSL by the Investee for in-house services provided and other expenses was immaterial. Mr. Gottesman is not on the board of the Investee and will not serve on its board unless approved by the Company’s board of directors. Mr. Gottesman holds a minority position in PSL. As of March 31, 2023, the carrying values of the Company’s notes were $1.8 million, as recorded in notes receivable from related parties within the condensed consolidated balance sheets. For the three months ended March 31, 2023, the Company recorded losses of $0.3 million within loss from equity method investments in the condensed consolidated statements of operations, representing its proportionate share of net income or loss based on the Investee’s financial results. No loss was recorded for the three months ended March 31, 2022 as the Company had not yet invested in the Investee. As the Company’s basis in the Investee’s common stock as accounted for under the equity method was valued at zero, the Company’s proportionate share of losses resulted in a reduction to the carrying value of the convertible note investments. The fair value of the convertible notes was determined to be equal to the face value of the convertible note. As such, the Company recognized an incremental fair value adjustment of $0.3 million within change in fair value of other investments on the condensed consolidated statements of operations for the three months ended March 31, 2023. No incremental fair value adjustment was recorded for the three months ended March 31, 2022. There were no impairment charges for the three months ended March 31, 2023 and 2022. See Note 5—Fair Value for more information on the fair value of the convertible note.

Fair Value

Fair Value	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value	Fair Value The following table presents the placement in the fair value hierarchy of assets and liabilities that are measured at fair value on a recurring basis (in thousands): March 31, 2023 Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market funds $ 56,134 $ — $ — $ 56,134 Commercial paper — 6,776 — 6,776 Investments: Commercial paper — 51,292 — 51,292 Corporate securities — 19,757 — 19,757 US Government securities — 103,398 — 103,398 Asset-backed securities — 7,521 — 7,521 Agency bonds — 6,577 — 6,577 Other investments: Convertible notes — — 1,810 1,810 Total assets measured at fair value $ 56,134 $ 195,321 $ 1,810 $ 253,265 December 31, 2022 Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market funds $ 23,006 $ — $ — $ 23,006 Commercial paper — 7,954 — 7,954 Investments: Commercial paper — 54,800 — 54,800 Corporate securities — 38,040 — 38,040 US Government securities — 107,759 — 107,759 Asset-backed securities — 8,234 — 8,234 Agency bonds — 4,977 — 4,977 Other investments: Convertible notes — — 1,810 1,810 Total assets measured at fair value $ 23,006 $ 221,764 $ 1,810 $ 246,580 The following table provides a reconciliation of the beginning and ending balances for the Level 3 financial assets measured at fair value using significant unobservable inputs (in thousands): Convertible Notes Balance at December 31, 2022 $ 1,810 Additions during the period — Proportionate share of equity method losses (314) Incremental change in fair value 314 Balance at March 31, 2023 $ 1,810 The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each period. There were no transfers of financial instruments between valuation levels during the periods presented. The Company classifies financial instruments as Level 2 within the fair value hierarchy which are valued on the basis of prices from an orderly transaction between market participants provided by reputable dealers or pricing services. Prices of these securities are obtained through independent, third-party pricing services and include market quotations that may include both observable and unobservable inputs. In determining the value of a particular investment, pricing services may use certain information with respect to transactions in such investments, quotations from dealers, pricing matrices and market transactions in comparable investments and various relationships between investments. Valuation of Convertible Note Investments As described in Note 4—Investments — Other Investments—Convertible Notes (Related Party Transaction) , the Company holds convertible note investments in the Investee that are measured at fair value. As of March 31, 2023, these convertible notes are held at a fair value of $1.8 million, The fair value of the notes is based predominantly on the credit quality of the underlying business and its ability to repay principal and interest, as well as the potential outcome of future equity financing transactions that may trigger the conversion feature provided by the notes. The Company classifies financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model. In addition to these unobservable inputs, the valuation models for Level 3 financial instruments typically also rely on a number of inputs that are readily observable, either directly or indirectly. The Company’s assessment of a particular input to the fair value measurement requires management to make judgments and consider factors specific to the liability. The fair value hierarchy requires the use of observable market data when available in determining fair value. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each period. Valuation of Private Placement Warrant Derivative Liability In December 2021, the Company announced that, pursuant to the terms of the Warrant Agreement, it would redeem all of the outstanding private placement warrants (“Private Warrants”) held by Nebula Caravel Holdings, LLC, the sponsor of Caravel and a greater than five percent stockholder of the Company (the “Sponsor”), and public warrants (“Public Warrants” and, collectively with the Private Warrants, “Warrants”) that remained outstanding at 5:00 p.m. New York City time on January 12, 2022 (the “Redemption Date”). In January 2022, the Company issued 2,046,220 shares of the Company’s Class A common stock, par value $0.0001 per share (“Class A Common Stock”), related to the December 2021 and January 2022 cashless exercise of 5,425,349 Public Warrants and 2,574,164 Private Warrants, representing approximately 98.6% of the Public Warrants and 100% of the Private Warrants, respectively. Holders of Warrants received 0.2558 shares of Class A Common Stock per Warrant in lieu of receiving a redemption price of $0.10 per Warrant (the “Redemption Price”) . A total of 74,631 Public Warrants remained unexercised after the Redemption Date and broker protect period and the Company redeemed those unexercised Public Warrants. Pursuant to the redemption, the Public Warrants ceased trading on The Nasdaq Global Market effective as of the close of trading on the Redemption Date, and were delisted after market close on the Redemption Date. As of March 31, 2023, no Warrant liabilities were outstanding as

Balance Sheet Components

Balance Sheet Components	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Components	Balance Sheet Components Property and Equipment, net The following table presents the detail of property and equipment, net as follows (in thousands): March 31, December 31, Computers $ 1,413 $ 1,452 Furniture and fixtures 3,783 3,777 Leasehold improvements 13,809 13,808 Internal-use software 22,098 21,652 Asset retirement obligation 225 225 Total property and equipment 41,328 40,914 Less: Accumulated depreciation and amortization (21,919) (21,396) Total property and equipment, net $ 19,409 $ 19,518 Depreciation and amortization of property and equipment was $1.0 million for both the three months ended March 31, 2023 and 2022. Depreciation and amortization of property and equipment was recorded to depreciation and amortization in the condensed consolidated statements of operations. The Company capitalized $2.5 million and $1.9 million of software development costs during the three months ended March 31, 2023 and 2022, respectively. Internal-use software amortization was $1.7 million for both the three months ended March 31, 2023 and 2022. Internal-use software amortization was recorded to cost of revenue (exclusive of depreciation and amortization shown separately) in the condensed consolidated statements of operations. Accrued Expenses and Other Current Liabilities The following table presents the detail of accrued expenses and other current liabilities as follows (in thousands): March 31, December 31, Income and other tax liabilities 1,920 1,670 Accrued legal expenses and open claims 862 686 Accrued legal settlements (1) 18,000 18,000 Accrued professional services 733 435 Holdback related to business combination 1,343 1,343 Accrued share repurchase 399 — Other current liabilities 601 560 Total accrued expenses and other current liabilities $ 23,858 $ 22,694 __________________ (1) See Note 8— Commitments and Contingencies for more information.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	3 Months Ended
	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill The Company tests goodwill by reporting unit for impairment on an annual basis or more frequently if events or changes in circumstances indicate that the asset might be impaired. No impairment of goodwill was recognized during any of the periods presented. Intangible Assets The gross book value and accumulated amortization of intangible assets were as follows (in thousands): March 31, 2023 Gross Book Accumulated Net Book Pet parent relationships $ 6,600 $ (3,681) $ 2,919 Shelter relationships 776 (117) 659 Technologies 1,696 (424) 1,272 Tradenames 1,302 (195) 1,107 Training curriculum 551 (138) 413 Total $ 10,925 $ (4,555) $ 6,370 December 31, 2022 Gross Book Accumulated Net Book Pet parent relationships $ 6,600 $ (3,478) $ 3,122 Shelter relationships 834 (135) 699 Technologies 1,696 (283) 1,413 Tradenames 1,302 (130) 1,172 Training curriculum 551 (92) 459 Total $ 10,983 $ (4,118) $ 6,865 The weighted average amortization period remaining as of March 31, 2023 for each class of intangible assets were as follows (in years): Pet parent relationships 3.6 Shelter relationships 4.3 Technologies 2.3 Tradenames 4.3 Training curriculum 2.3 Amortization expense related to acquired intangible assets for the three months ended March 31, 2023 and 2022 was $0.5 million and $0.7 million, respectively. The Company did not recognize any intangible asset impairment losses for any of the periods presented. Based on amounts recorded at March 31, 2023, the Company estimates intangible asset amortization expense in each of the years ending December 31 as follows (in thousands): Remainder of 2023 $ 1,484 2024 1,979 2025 1,605 2026 1,094 2027 208 Thereafter — Total $ 6,370

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Leases The Company leases certain office space in Seattle and Spokane, Washington and Barcelona, Spain with lease agreements expiring between 2023 and 2030. These leases require monthly lease payments that may be subject to annual increases throughout the lease term. Certain of these leases also include renewal options at the election of the Company to renew or extend the lease for an additional one In September 2018, the Company entered into a non-cancellable sublease agreement for a portion of one of its leased facilities that commenced on November 1, 2018, which was subsequently amended to extend the term for an additional two years in February 2020. In May 2022, the Company amended the sublease to extend the term for an additional one year. In December 2022, the Company amended the sublease to extend the term for one In April 2021, the Company entered into a non-cancellable sublease agreement for a portion of one of its leased facilities that commenced on September 1, 2021. As of March 31, 2023, under the terms of the sublease agreement, the Company will receive $0.8 million in base lease payments plus reimbursement of certain operating expenses over the remaining term of the sublease, which ends in August 2024. The subtenant has the option to renew the sublease for one Sublease income is recognized on a straight-line basis over the sublease term and is recorded as a reduction to operating lease cost within general and administrative costs in the condensed consolidated statements of operations. The components of lease cost were as follows (in thousands): Three Months Ended 2023 2022 Operating lease cost $ 981 $ 1,065 Short-term lease cost 159 — Sublease income (296) (304) Total lease cost $ 844 $ 761 Other information related to leases was as follows (in thousands): Three Months Ended 2023 2022 Cash paid for operating lease liabilities $ 1,419 $ 1,153 Lease term and discount rate were as follows: As of March 31, 2023 As of December 31, 2022 Weighted-average discount rate 7.28 % 7.27 % Weighted-average remaining lease term (years) 6.58 6.82 Maturities of lease liabilities were as follows as of March 31, 2023 (in thousands): Year Ending December 31 Amounts Remainder of 2023 $ 3,000 2024 4,569 2025 4,693 2026 4,430 2027 4,353 Thereafter 9,430 Total lease payments 30,475 Less: imputed interest (6,527) Present value of lease liabilities 23,948 Less: current portion of lease liabilities (2,478) Total lease liabilities, noncurrent $ 21,470 Letters of Credit The Company maintains a $3.5 million unsecured letter of credit from third-party financial institutions related to the security deposit on its Seattle headquarters and Spokane office space. Guarantees and Indemnification In the ordinary course of business to facilitate sales of its services, the Company has entered into agreements with, among others, suppliers, and partners that include guarantees or indemnity provisions. The Company also enters into indemnification agreements with its officers and directors, and the Company’s certificate of incorporation and bylaws include similar indemnification obligations to its officers and directors. To date, there have been no claims under any indemnification provisions, therefore there is no accrual of such amounts for any of the periods presented. The Company is unable to determine the maximum potential impact of these indemnifications on the condensed consolidated financial statements and maintains director and officer insurance coverage that would generally enable it to recover a portion of any future amounts paid for director and officer indemnification obligations. Litigation and Other Contingencies From time to time, the Company is or may become party to litigation and subject to claims incurred in the ordinary course of business, including personal injury and indemnification claims, intellectual property claims, labor and employment claims, threatened claims, breach of contract claims, and other types of claims, class action and representative lawsuits, and actions brought by government authorities, alleging violations of employment classification laws, labor and other laws that would apply to employees, consumer protection laws, data protection laws, or other laws. In addition, in the ordinary course of business, the Company’s Trust and Safety team receives claims pursuant to the Rover Guarantee, as well as claims and threats of legal action that arise from pet care services booked through the Company’s website and/or applications. Various parties have from time to time claimed, and may claim in the future, that the Company is liable for damages related to accidents or other incidents involving pets, pet parents, pet care providers, and third parties. The Company regularly evaluates the status of legal proceedings and regulatory matters in which it is involved to assess whether a loss is probable or there is a reasonable possibility that a loss or additional loss may have been incurred to determine if accruals are appropriate. The Company accrues a liability when management believes information available prior to the issuance of the condensed consolidated financial statements indicates it is probable a loss has been incurred as of the date of the condensed consolidated financial statements and the amount of loss can be reasonably estimated. The Company adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. Legal costs are expensed as incurred. Although the results of litigation, claims and regulatory matters are inherently unpredictable, management concluded, based on currently available information, that there was not a reasonable possibility that the Company had incurred a material and estimable loss during the periods presented related to such loss contingencies. On August 22, 2018, a pet care provider filed a representative action under California’s Private Attorney General Act (“PAGA”) in California Superior Court, captioned Erika Miller v. A Place for Rover, Inc. , alleging that the Company misclassified pet care providers in California as independent contractors in violation of the California Labor Code, alleging various wage and hour claims under the California Labor Code, and seeking injunctive relief, civil penalties, attorney’s fees, and other forms of relief. After the Company successfully removed the case to the U.S. District Court for the Northern District of California (the “District Court”), a nother pet care provider was substituted as plaintiff in the case, now captioned Melanie Sportsman v. A Place for Rover, Inc . On May 6, 2021, the District Court granted the Company’s motion for summary judgment and entered judgment in the Company’s favor, closing the case, but the plaintiff filed a notice of appeal of the District Court’s dismissal with the U.S. Court of Appeals for the Ninth Circuit (the “Ninth Circuit”). Following oral argument before the Ninth Circuit on August 29, 2022, the Company and the plaintiff engaged in settlement discussions and mediations resulting in a binding settlement term sheet between the Company and the named plaintiff on October 20, 2022. The Company recorded the $18.0 million total settlement payment provided for in the binding settlement term sheet under general and administrative expense in the condensed consolidated statements of operations for the year ended December 31, 2022 and within accrued expenses and other current liabilities on the condensed consolidated balance sheets as of December 31, 2022. At the parties’ request, the Ninth Circuit dismissed the appeal without prejudice and remanded to the District Court for settlement approval, subject to reinstatement with the Ninth Circuit in the event the District Court declines to approve the settlement. On January 12, 2023, the Company and the named plaintiff entered into a comprehensive settlement agreement and release of claims pursuant to which the Company will make the total settlement payment of $18.0 million, which includes all related settlement costs, in full and final settlement of all claims that the named plaintiff and members of a proposed settlement class and a PAGA group have brought or could bring in the litigation, including claims under PAGA, the California Labor Code, and similar statutes through the District Court’s final order approving the settlement agreement. The proposed settlement class consists of all pet care providers who performed at least one service in California booked through the Rover platform during the period from November 1, 2018 through February 7, 2023, the date on which the motion for preliminary approval of the settlement was filed with the District Court. In addition, pet care providers who performed at least one service in California booked through the Rover platform between June 11, 2017 and February 7, 2023 would receive more limited relief related to PAGA included as part of the overall settlement. The Company also agreed to modify the Rover platform to make certain changes applicable to pet care providers in California to bolster the classification of pet care providers who use the Rover platform as independent contractors under California law. On March 24, 2023, the District Court preliminarily approved the settlement agreement. The District Court hearing for final approval of the settlement is scheduled for July 19, 2023. Final settlement is subject to, among other things, the Company not exercising its right to terminate the settlement if too many proposed class members seek exclusion from the settlement, District Court approval of the settlement, and the resolution (or absence) of any appeals or requests for review that may be filed after the District Court’s approval. In settling the case, the Company is not admitting any wrongdoing or liability. The Company expects to pay the $18.0 million total settlement payment from existing cash and cash equivalents and investments during 2023, contingent on final approval of the settlement. While litigation is inherently unpredictable and the ultimate outcomes cannot be predicted with certainty, the Company believes it has valid defenses with respect to the legal matters pending against it. Nevertheless, the Company’s condensed consolidated financial statements could be materially adversely affected in a particular period by the resolution of one or more of these contingencies. Accrued liabilities established to provide for contingencies are adjusted as further information develops, circumstances change, or contingencies are resolved; and such changes are recorded in the accompanying condensed consolidated statements of operations during the period of the change and reflected in accrued expenses and other current liabilities on the accompanying condensed consolidated balance sheets. Until the final resolution of legal matters, there may be an exposure to losses in excess of the amounts accrued. Regardless of the outcome, litigation can have an adverse impact on the Company because of defense and settlement costs, diversion of management resources, and other factors. The Company may also find itself at greater risk to outside party claims or regulatory actions as it increases and continues its operations in jurisdictions where the laws with respect to the potential liability of online marketplaces or the employment classification of pet care providers who use online marketplaces are uncertain, unfavorable or unclear. Additionally, from time to time, the Company has been or may become subject to audit by taxing authorities or subject to other forms of inspection or audit, including audits related to employment classification matters. Due to the uncertainties inherent in the final outcome of such matters, the Company can give no assurance that it will prevail in such matters which could have an adverse effect on the Company’s condensed consolidated financial statements. As of March 31, 2023 and except for the specific matter noted above, the Company was not aware of any currently pending legal matters or claims, individually or in the aggregate, that are expected to have a material adverse effect on its condensed consolidated financial statements.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity Public and Private Warrants In January 2022, the Company issued 2,046,220 shares of Class A Common Stock related to the December 2021 and January 2022 cashless exercise of 5,425,349 Public Warrants and 2,574,164 Private Warrants, representing approximately 98.6% of the Public Warrants and 100% of the Private Warrants, respectively. Holders of Warrants who chose to cashless exercise their Warrants received 0.2558 shares of Class A Common Stock per Warrant in lieu of receiving the Redemption Price. A total of 74,631 Public Warrants remained unexercised after the Redemption Date and broker protect period and the Company redeemed those unexercised Public Warrants. Pursuant to the redemption, the Public Warrants ceased trading on The Nasdaq Global Market effective as of the close of trading on the Redemption Date, and were delisted after market close on the Redemption Date. As of March 31, 2023, the Company had no Warrants outstanding. The Warrants were classified as a liability prior to exercise and redemption and measured at fair value with the change in fair value reported in the statement of operations. Upon the cashless exercise of such Warrants to Class A Common Stock, the related carrying amount of the warrant liability was reclassified to stockholders’ equity. Share Repurchase Program In February 2023, the Company announced that its board of directors approved a share repurchase program with authorization to purchase up to $50.0 million (exclusive of brokers’ commissions and expenses) of the Class A Common Stock (the “Share Repurchase Program”). The Share Repurchase Program will be in place for up to 12 months. Under the Share Repurchase Program, repurchases may be made on a discretionary basis from time to time, subject to general business and market conditions, through open market transactions (including through Rule 10b5-1 trading plans) or through privately negotiated transactions. All shares repurchased under the Share Repurchase Program are retired and returned to authorized and unissued status. The repurchases are funded from existing cash and cash equivalents and investments. The Share Repurchase Program does not obligate us to repurchase any specific dollar amount or to acquire any specific number of shares. The Share Repurchase Program may be modified, suspended, or terminated at any time at the discretion of the Company’s board of directors. When shares are repurchased for retirement, the cost of the repurchased shares is deducted from stockholders’ equity, with their par value being deducted from common stock and the excess of the repurchase cost over the par value being deducted from accumulated deficit. The Company excludes shares repurchased but not yet settled from the calculation of basic and diluted earnings per share. The Inflation Reduction Act of 2022, which was enacted into law on August 16, 2022, imposed a nondeductible 1% excise tax on the net value of certain stock repurchases made after December 31, 2022. Excise tax accrued was immaterial for the three months ended March 31, 2023. The following table presents the open-market share purchase activity, exclusive of brokers’ commissions and excise tax (in thousands, except share and per share data): Three Months Ended 2023 2022 Total number of shares purchased 720,097 — Average price paid per share $ 4.22 $ — Total cost $ 3,041 $ —

Stock-Based Compensation

Stock-Based Compensation	3 Months Ended
	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation 2021 Equity Incentive Plan The Company adopted the 2021 Equity Incentive Plan (the “2021 Plan”) under which 17.2 million shares of Class A Common Stock were initially reserved for issuance, plus up to 20.4 million shares subject to stock options that were assumed in the Merger and expire or otherwise terminate without having been exercised in full, are tendered to or withheld by the Company for payment of an exercise price or for tax withholding obligations, or are forfeited to or repurchased by the Company due to failure to vest. The 2021 Plan permits the grant of incentive and non-qualified stock options, restricted stock, restricted stock units and other stock-based awards to employees, directors, and consultants of the Company. As of March 31, 2023, the Company had 8.6 million shares of Class A Common Stock reserved for future issuance under the 2021 Plan, which includes shares subject to stock options that were assumed in the Merger that expired or otherwise terminated without having been exercised in full or were forfeited due to failure to vest. Equity Awards Available for Grant A summary of equity awards available for grant is as follows (in thousands): Equity Available Balances as of December 31, 2022 7,881 Equity awards authorized 9,226 Equity awards granted (8,879) Equity awards canceled and forfeited 147 Equity awards withheld under net share settlement 184 Balances as of March 31, 2023 8,559 Stock Options A summary of stock option activity is as follows (in thousands, except per share amounts and years): Number of Weighted- Weighted- Aggregate Balance as of December 31, 2022 14,363 $ 1.71 4.9 $ 28,251 Options exercised (1,039) 1.45 Options canceled and forfeited (4) 2.72 Balances as of March 31, 2023 13,320 $ 1.73 4.8 $ 37,343 Options vested and exercisable – March 31, 2023 12,456 $ 1.70 4.6 $ 35,218 There were no options granted during the three months ended March 31, 2023 and 2022. The aggregate intrinsic value of stock options exercised during the three months ended March 31, 2023 and 2022 was $2.9 million and $10.0 million, respectively. The fair value of options vested during the three months ended March 31, 2023 and 2022 was $0.5 million and $0.8 million, respectively. Restricted Stock Units Restricted stock units (“RSUs”) are measured at the fair market value of the underlying stock at the grant date and the expense is recognized over the requisite service period. The service-based vesting condition for these awards is generally satisfied over four years. A summary of RSU activity is as follows (in thousands, except per share amounts): Number of Weighted- Aggregate Unvested December 31, 2022 7,622 $ 6.22 $ 27,975 Granted 8,879 3.85 Vested (1) (492) 7.15 Forfeited (143) 6.17 Unvested March 31, 2023 15,866 $ 4.86 $ 71,877 __________________ (1) Includes 183,674 shares vested but not issued due to net share settlement for payment of employee taxes. These shares that were withheld under net share settlement remain in the authorized but unissued pool under the 2021 Plan and can be reissued by the Company. Payment of employee taxes due to net share settlement are reflected as a financing activity within the condensed consolidated statements of cash flows. The total fair value of RSUs vested during the three months ended March 31, 2023 and 2022 was $3.5 million and $2.5 million, respectively. Stock-Based Compensation The following table summarizes stock-based compensation expense recorded in each component of operating expenses in the Company’s condensed consolidated statements of operations for the presented periods (in thousands): Three Months Ended 2023 2022 Operations and support $ 428 $ 348 Marketing 263 251 Product development 1,098 1,390 General and administrative 2,716 2,321 Total stock-based compensation expense $ 4,505 $ 4,310 No material income tax benefit related to stock-based compensation was recorded during the three months ended March 31, 2023 and 2022 as the Company maintained a full valuation allowance against its net deferred tax assets within the United States. As of March 31, 2023, total unrecognized compensation cost related to unvested stock options was $0.8 million, which was expected to be recognized over a weighted average remaining service period of 0.9 years. As of March 31, 2023, total unrecognized compensation cost related to unvested RSUs was $73.4 million, which was expected to be recognized over a weighted average remaining service period of 3.2 years.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income TaxesThe Company’s tax provision for interim periods is determined using an estimated annual effective tax rate, adjusted for discrete items in the related period. The effective tax rates for the three months ended March 31, 2023 and 2022 were 0.0% and (0.1)%, respectively. The effective tax rate differs from the statutory rate of 21% primarily due to the full valuation allowance on the U.S. deferred tax assets.During the three months ended March 31, 2023, the amount of gross unrecognized tax benefits increased by $38,500, of which none, if recognized, would affect the effective tax rate as these unrecognized tax benefits would increase deferred tax assets subject to a full valuation allowance.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	Net Loss Per Share Attributable to Common Stockholders The following table sets forth the computation of basic and diluted net loss per common share attributable to common stockholders (in thousands, except per share amounts): Three Months Ended 2023 2022 Numerator: Net loss $ (4,656) $ (8,146) Denominator: Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted 184,365 179,671 Net loss per share attributable to common stockholders, basic and diluted $ (0.03) $ (0.05) The following potentially dilutive shares were not included in the calculation of diluted shares outstanding for the periods presented as the effect would have been anti-dilutive (in thousands): March 31, 2023 2022 Outstanding stock options and RSUs 29,186 23,328 Sponsor earnout shares 492 492 Total 29,678 23,820 The Sponsor earnout shares noted above represent 492,326 unvested shares beneficially owned by the Sponsor and certain of its affiliates that will not vest until the Class A Common Stock achieves a volume weighted average price greater than or equal to $16.00 over any 20 trading days within any 30 trading day period (“Triggering Event III”) during the earnout period that expires in July 2028 (the “Earnout Period”). This share price was not achieved as of March 31, 2023.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Share Repurchase Program Subsequent to the end of the first quarter of 2023 and through the date of issuance of these financial statements, the Company repurchased an additional 990,498 shares for a total cost of $4.3 million, excluding brokers’ commissions and excise tax, representing an average purchase price of $4.38 per share.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation and Basis of PresentationThe unaudited condensed consolidated financial statements and accompanying notes include the accounts of the Company and its wholly owned subsidiaries, after elimination of all intercompany balances and transactions.
Basis of Presentation	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and the requirements of the U.S. Securities and Exchange Commission (the “SEC”) for interim financial information. Certain information and disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. Accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto for the year ended December 31, 2022. The information as of December 31, 2022 included in the condensed consolidated balance sheets was derived from those audited financial statements. The unaudited condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for the fair presentation of the Company’s financial information for the interim periods presented. The unaudited condensed consolidated results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any other future annual or interim period. Reclassifications Certain amounts previously presented for prior periods have been reclassified to conform to current presentation. These reclassifications did not affect assets, liabilities, net income, cash flows or equity for the periods presented.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated balance sheets and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions, include, but are not limited to, the capitalization and estimated useful life of the Company’s internal-use software development costs, the assumptions used in the valuation of leases, legal contingencies, and stock-based compensation expense. These estimates and assumptions are based on information available as of the date of the condensed consolidated financial statements; therefore, actual results could differ from management’s estimates. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.
Segment Information	Segment Information The Company has one operating segment and one reportable segment. As the Company’s chief operating decision maker, the chief executive officer, reviews financial information on a consolidated basis for purposes of allocating resources and evaluating financial performance. Substantially all long-lived assets are located in the United States and substantially all revenue is attributed to fees from pet parents and pet care providers based in the United States.
Foreign Currencies	Foreign CurrenciesForeign currency transaction gains and losses are a result of the effect of exchange rate changes on transactions denominated in currencies other than the functional currency. Gains and losses on those foreign currency transactions are included in determining net loss for the period of exchange and are recorded in other expense, net in the condensed consolidated statements of operations.
Certain Significant Risks and Uncertainties	Certain Significant Risks and Uncertainties The Company is subject to certain risks and challenges associated with other companies at a similar stage of development, including risks associated with: dependence on key personnel; marketing; adaptation to changing market dynamics and customer preferences; and potential competition including from larger companies that may have greater name recognition, longer operating histories, more and better established customer relationships and greater resources than the Company.
Concentrations of Credit Risk	Concentrations of Credit RiskFinancial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash, investments and accounts receivable. The Company maintains cash balances that may exceed the insured limits set by the Federal Deposit Insurance Corporation. The Company has not experienced any losses on its deposits of cash and cash equivalents. The Company reduces credit risk by placing cash and investment balances with major financial institutions that management assesses to be of high-credit quality and also limits purchases of debt securities to investment-grade securities. The Company regularly evaluates the credit rating for issuers of government and corporate debt securities that it holds and other non-financial third party institutions.
Revenue Recognition	Revenue Recognition Marketplace Platform Revenue The Company operates an online marketplace that provides a platform for pet parents and pet care providers to communicate and arrange for pet care services. The Company derives its revenue principally from pet parents’ and pet care providers’ use of the Company’s platform and related services that enable pet care providers to offer, book, and fulfill pet care services. The Company enters into its standard terms of service with pet care providers and pet parents who wish to use the Company’s platform. The terms of service define the rights and responsibilities of pet care providers and pet parents when using the Company’s platform as well as general payment terms. The Company charges a fixed percentage service fee for each arrangement of pet care services between the pet parent and the pet care provider on the Company’s platform (a booking). The fixed percentage service fees generally are established at the time a pet parent or pet care provider joined the platform and do not vary based on the volume of transactions. A booking defines the explicit fee from which the Company earns its fixed percentage service fee. The creation of a booking combined with the terms of service establish enforceable rights and obligations for the transaction. A contract exists between the pet care provider and the Company upon the creation of a booking and after the pet care providers’ cancellation period has lapsed. Pet parents are considered the Company’s customers to the extent that they pay a fixed percentage fee, generally up to a fixed dollar amount to the Company for the booking. Similarly, a contract exists between the pet parent and the Company upon the creation of a booking and after the pet care providers’ stated cancellation period has lapsed. Pet parents pay for services at the time of booking. The Company considers the facilitation of the connection between pet care provider and pet parent to be the promise in the contracts. This is consistent with the terms of service, as well as the substance of what a pet care provider or pet parent is expecting from the use of the Company’s platform. While customers have access to the use of the platform, customer support, and other activities, these activities are not considered distinct from each other in the context of the overall arrangement, which is the facilitation of a connection between a pet care provider and a pet parent. As such, the Company has determined that its sole performance obligation is to facilitate a connection between pet care providers and pet parents through its platform. The Company’s performance obligation is satisfied at a point-in-time when the connection has been completed, which is when the pet care provider and pet parent have completed a booking, any related cancellation period has lapsed, and the related underlying pet care services have begun. The Company derives revenue from pet care providers and pet parents primarily in the United States, as well as Canada, the United Kingdom and Western Europe. Judgment is required in determining whether the Company is the principal or agent in transactions with pet care providers and pet parents. The Company evaluates the presentation of revenue on a gross or net basis based on whether it controls the service provided to the pet parent and is therefore the principal, or the Company arranges for other parties to provide the service to the pet parent and is therefore the agent. The Company has concluded it is the agent in transactions with pet care providers and pet parents because, among other factors, it is not responsible for the delivery of pet care services provided by the pet care provider to the pet parent. Accordingly, the Company recognizes revenue on a net basis, representing the fee the Company expects to receive in exchange for providing access to the Company’s platform to pet care providers and pet parents. The Company has no significant financing components in its contracts with customers. The Company recognizes revenue net of any sales tax paid related to its revenue transactions. Provider Onboarding Revenue The Company earns revenue from non-refundable provider onboarding fees by completing quality assurance reviews of new pet care provider profiles including obtaining background checks, which are performed by a third party. Pet care providers pay the onboarding fee at the time of sign up. The Company recognizes revenue related to provider onboarding services at a point-in-time upon satisfaction of the related performance obligation, determined to be the completion of the quality assurance review of the pet care provider’s profile including a background check. The Company is considered to be a principal in these transactions and recognizes revenue on a gross basis. Costs associated with performing the pet care provider onboarding review are recognized in cost of revenue (exclusive of depreciation and amortization shown separately). Payments to Customers From time to time, the Company makes payments to pet parents and pet care providers as part of its marketing promotions, incentive programs and refund activities. Marketing Promotions and Incentive Programs The Company encourages the use of its platform and attracts new customers through its marketing promotions and incentive programs. The Company uses marketing promotions in tandem with sales and marketing spend to attract new pet parents to its platform. Promotions offered to pet parents in the form of credits, coupons or discounts are recorded as a reduction of revenue or marketing expense. The Company offers referral credits to its existing pet parents or pet care providers for referrals of new pet parents or pet care providers. These referral credits are paid in exchange for a distinct marketing service and therefore the portion of these credits that is equal to or less than the cost of acquiring a new pet parent or pet care provider are accounted for as a customer acquisition cost. These new customer acquisition costs are expensed as incurred and reflected as marketing expenses in the Company’s condensed consolidated statements of operations. The portion of these credits in excess of the fair value of acquiring a new pet parent or pet care provider is accounted for as a reduction of revenue. On occasion, the Company offers promotional discounts to existing pet parents. The Company records incentives provided to existing pet parents as a promotion and reduces revenue on the date that the corresponding revenue transaction is recorded. Refunds In certain instances, the Company issues refunds to pet parents as part of its customer support activities for customer satisfaction matters in the form of credits to be applied toward a future booking. The Company accounts for such refunds as variable consideration and therefore records the amount of each refund or credit issued as a reduction of revenue. Pet Parent Deposits and Pet Care Provider Liabilities The Company records payments received from pet parents, excluding the revenue portion due to the Company, in advance of the related services being provided as pet parent deposits. As the related performance obligations are satisfied, these amounts are settled through our payment processor and derecognized. In addition, we hold pet care provider liabilities relating to stays completed prior to the implementation of our current payment processor and related systems where payment has not yet been requested by the pet care provider. The Company is subject to compliance with escheat laws applicable by jurisdiction where pet care providers do not claim the amounts owed to them for services rendered. Rover Guarantee In connection with services provided to facilitate the connections between pet care provider and pet parent, the Company provides a contractual guarantee to reimburse pet parents or pet care providers for certain expenses arising from injuries or other damages incurred during a service booked through the Company’s platform, subject to specified conditions (the “Rover Guarantee”). The Company’s obligation under the Rover Guarantee is accounted for in accordance with Accounting Standards Codification Topic 460, Guarantees
Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements	Recently Adopted Accounting Pronouncements The Company is provided the option to adopt new or revised accounting guidance as an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) either (1) within the same periods as those otherwise applicable to public business entities, or (2) within the same time periods as private companies, including early adoption when permissible. The Company has elected to adopt new or revised accounting guidance within the same time period as public business entities, as indicated below. In March 2022, the FASB issued ASU No. 2022-02 Financial Instruments—Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures. The amendment in this ASU provides an update to: (1) troubled debt restructurings guidance in Subtopic 310-40 and enhances disclosure requirements for certain loan refinancings and restructurings; and (2) requires public entities to disclose current period gross write-offs by year of origination for financing receivables and net investments in leases. The guidance is effective for the Company for the year beginning after December 15, 2022. The Company adopted this standard on January 1, 2023 using the prospective transition method. The adoption of the new standard did not have a material impact on the Company’s condensed consolidated financial statements. Recently Issued Accounting Pronouncements In June 2022, the FASB issued ASU No. 2022-03 Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restriction. The amendment in this ASU clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. This amendment also requires public entities to add certain disclosures for equity securities subject to contractual sale restrictions. The guidance is effective for the Company for the year beginning after December 15, 2023. The Company will adopt this standard on January 1, 2024 using the prospective transition method. We do not expect the adoption of the new standard to have a material impact on the Company’s condensed consolidated financial statements but will continue to evaluate the new standard in future accounting periods.

Revenue from Contract with Cust

Revenue from Contract with Customer (Tables)	3 Months Ended
	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Contract Liabilities	The changes in the Company’s deferred revenue balances were as follows (in thousands): Balance at December 31, 2022 $ 5,544 Bookings and other 46,630 Revenue recognized (39,248) Balance at March 31, 2023 $ 12,926

Investments (Tables)

Investments (Tables)	3 Months Ended
	Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Schedule of Available-for-sale Securities Reconciliation	March 31, 2023 Amortized Costs Gross Unrealized Gains Gross Unrealized Losses Fair Value Marketable securities: Commercial paper $ 51,327 $ — $ (35) $ 51,292 Corporate securities 19,841 — (84) 19,757 US Government securities 103,780 9 (391) 103,398 Asset-backed securities 7,554 — (33) 7,521 Agency bonds 6,560 17 — 6,577 Total marketable securities 189,062 26 (543) 188,545 Other investments: Convertible notes 1,810 — — 1,810 Total other investments 1,810 — — 1,810 Total investments $ 190,872 $ 26 $ (543) $ 190,355 December 31, 2022 Amortized Costs Gross Unrealized Gains Gross Unrealized Losses Fair Value Marketable securities: Commercial paper $ 54,851 $ — $ (51) $ 54,800 Corporate securities 38,260 — (220) 38,040 US Government securities 108,551 — (792) 107,759 Asset-backed securities 8,269 — (35) 8,234 Agency bonds 4,989 — (12) 4,977 Total marketable securities 214,920 — (1,110) 213,810 Other investments: Convertible notes 1,810 — — 1,810 Total other investments 1,810 — — 1,810 Total investments $ 216,730 $ — $ (1,110) $ 215,620
Investments Classified by Contractual Maturity Date	The contractual maturity of the available-for-sale investments were as follows (in thousands): March 31, 2023 Within 1 year 1 to 5 years More than 5 years Total Marketable securities: Commercial paper $ 51,292 $ — $ — $ 51,292 Corporate securities 17,553 2,204 — 19,757 US Government securities 101,005 2,393 — 103,398 Asset-backed securities — 7,521 — 7,521 Agency bonds 6,577 — — 6,577 Total marketable securities 176,427 12,118 — 188,545 Other investments: Convertible notes 1,810 — — 1,810 Total other investments 1,810 — — 1,810 Total investments $ 178,237 $ 12,118 $ — $ 190,355 December 31, 2022 Within 1 year 1 to 5 years More than 5 years Total Marketable securities: Commercial paper $ 54,800 $ — $ — $ 54,800 Corporate securities 32,767 5,273 — 38,040 US Government securities 101,289 6,470 — 107,759 Asset-backed securities — 8,234 — 8,234 Agency bonds 2,491 2,486 — 4,977 Total marketable securities 191,347 22,463 — 213,810 Other investments: Convertible notes 1,810 — — 1,810 Total other investments 1,810 — — 1,810 Total investments $ 193,157 $ 22,463 $ — $ 215,620

Fair Value (Tables)

Fair Value (Tables)	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis	The following table presents the placement in the fair value hierarchy of assets and liabilities that are measured at fair value on a recurring basis (in thousands): March 31, 2023 Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market funds $ 56,134 $ — $ — $ 56,134 Commercial paper — 6,776 — 6,776 Investments: Commercial paper — 51,292 — 51,292 Corporate securities — 19,757 — 19,757 US Government securities — 103,398 — 103,398 Asset-backed securities — 7,521 — 7,521 Agency bonds — 6,577 — 6,577 Other investments: Convertible notes — — 1,810 1,810 Total assets measured at fair value $ 56,134 $ 195,321 $ 1,810 $ 253,265 December 31, 2022 Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market funds $ 23,006 $ — $ — $ 23,006 Commercial paper — 7,954 — 7,954 Investments: Commercial paper — 54,800 — 54,800 Corporate securities — 38,040 — 38,040 US Government securities — 107,759 — 107,759 Asset-backed securities — 8,234 — 8,234 Agency bonds — 4,977 — 4,977 Other investments: Convertible notes — — 1,810 1,810 Total assets measured at fair value $ 23,006 $ 221,764 $ 1,810 $ 246,580
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation	The following table provides a reconciliation of the beginning and ending balances for the Level 3 financial assets measured at fair value using significant unobservable inputs (in thousands): Convertible Notes Balance at December 31, 2022 $ 1,810 Additions during the period — Proportionate share of equity method losses (314) Incremental change in fair value 314 Balance at March 31, 2023 $ 1,810

Balance Sheet Components (Table

Balance Sheet Components (Tables)	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Property, Plant and Equipment	The following table presents the detail of property and equipment, net as follows (in thousands): March 31, December 31, Computers $ 1,413 $ 1,452 Furniture and fixtures 3,783 3,777 Leasehold improvements 13,809 13,808 Internal-use software 22,098 21,652 Asset retirement obligation 225 225 Total property and equipment 41,328 40,914 Less: Accumulated depreciation and amortization (21,919) (21,396) Total property and equipment, net $ 19,409 $ 19,518
Schedule of Accrued Expenses and Other Current Liabilities	The following table presents the detail of accrued expenses and other current liabilities as follows (in thousands): March 31, December 31, Income and other tax liabilities 1,920 1,670 Accrued legal expenses and open claims 862 686 Accrued legal settlements (1) 18,000 18,000 Accrued professional services 733 435 Holdback related to business combination 1,343 1,343 Accrued share repurchase 399 — Other current liabilities 601 560 Total accrued expenses and other current liabilities $ 23,858 $ 22,694 __________________ (1) See Note 8— Commitments and Contingencies for more information.
Schedule of Accrued Expenses and Other Current Liabilities	The following table presents the detail of accrued expenses and other current liabilities as follows (in thousands): March 31, December 31, Income and other tax liabilities 1,920 1,670 Accrued legal expenses and open claims 862 686 Accrued legal settlements (1) 18,000 18,000 Accrued professional services 733 435 Holdback related to business combination 1,343 1,343 Accrued share repurchase 399 — Other current liabilities 601 560 Total accrued expenses and other current liabilities $ 23,858 $ 22,694 __________________ (1) See Note 8— Commitments and Contingencies for more information.

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	The gross book value and accumulated amortization of intangible assets were as follows (in thousands): March 31, 2023 Gross Book Accumulated Net Book Pet parent relationships $ 6,600 $ (3,681) $ 2,919 Shelter relationships 776 (117) 659 Technologies 1,696 (424) 1,272 Tradenames 1,302 (195) 1,107 Training curriculum 551 (138) 413 Total $ 10,925 $ (4,555) $ 6,370 December 31, 2022 Gross Book Accumulated Net Book Pet parent relationships $ 6,600 $ (3,478) $ 3,122 Shelter relationships 834 (135) 699 Technologies 1,696 (283) 1,413 Tradenames 1,302 (130) 1,172 Training curriculum 551 (92) 459 Total $ 10,983 $ (4,118) $ 6,865 The weighted average amortization period remaining as of March 31, 2023 for each class of intangible assets were as follows (in years): Pet parent relationships 3.6 Shelter relationships 4.3 Technologies 2.3 Tradenames 4.3 Training curriculum 2.3
Schedule of Intangible Assets, Future Amortization Expense	Based on amounts recorded at March 31, 2023, the Company estimates intangible asset amortization expense in each of the years ending December 31 as follows (in thousands): Remainder of 2023 $ 1,484 2024 1,979 2025 1,605 2026 1,094 2027 208 Thereafter — Total $ 6,370

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Schedule of Lease Cost and Other Information	The components of lease cost were as follows (in thousands): Three Months Ended 2023 2022 Operating lease cost $ 981 $ 1,065 Short-term lease cost 159 — Sublease income (296) (304) Total lease cost $ 844 $ 761 Other information related to leases was as follows (in thousands): Three Months Ended 2023 2022 Cash paid for operating lease liabilities $ 1,419 $ 1,153 Lease term and discount rate were as follows: As of March 31, 2023 As of December 31, 2022 Weighted-average discount rate 7.28 % 7.27 % Weighted-average remaining lease term (years) 6.58 6.82
Schedule of Operating Lease Maturity	Maturities of lease liabilities were as follows as of March 31, 2023 (in thousands): Year Ending December 31 Amounts Remainder of 2023 $ 3,000 2024 4,569 2025 4,693 2026 4,430 2027 4,353 Thereafter 9,430 Total lease payments 30,475 Less: imputed interest (6,527) Present value of lease liabilities 23,948 Less: current portion of lease liabilities (2,478) Total lease liabilities, noncurrent $ 21,470

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
Schedule Of Shares Repurchased And Retired	The following table presents the open-market share purchase activity, exclusive of brokers’ commissions and excise tax (in thousands, except share and per share data): Three Months Ended 2023 2022 Total number of shares purchased 720,097 — Average price paid per share $ 4.22 $ — Total cost $ 3,041 $ —

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Equity Awards Available for Grant	A summary of equity awards available for grant is as follows (in thousands): Equity Available Balances as of December 31, 2022 7,881 Equity awards authorized 9,226 Equity awards granted (8,879) Equity awards canceled and forfeited 147 Equity awards withheld under net share settlement 184 Balances as of March 31, 2023 8,559
Schedule of Stock Option Activity	A summary of stock option activity is as follows (in thousands, except per share amounts and years): Number of Weighted- Weighted- Aggregate Balance as of December 31, 2022 14,363 $ 1.71 4.9 $ 28,251 Options exercised (1,039) 1.45 Options canceled and forfeited (4) 2.72 Balances as of March 31, 2023 13,320 $ 1.73 4.8 $ 37,343 Options vested and exercisable – March 31, 2023 12,456 $ 1.70 4.6 $ 35,218
Share-based Payment Arrangement, Restricted Stock Unit, Activity	A summary of RSU activity is as follows (in thousands, except per share amounts): Number of Weighted- Aggregate Unvested December 31, 2022 7,622 $ 6.22 $ 27,975 Granted 8,879 3.85 Vested (1) (492) 7.15 Forfeited (143) 6.17 Unvested March 31, 2023 15,866 $ 4.86 $ 71,877 __________________ (1) Includes 183,674 shares vested but not issued due to net share settlement for payment of employee taxes. These shares that were withheld under net share settlement remain in the authorized but unissued pool under the 2021 Plan and can be reissued by the Company. Payment of employee taxes due to net share settlement are reflected as a financing activity within the condensed consolidated statements of cash flows.
Schedule of Stock-Based Compensation Expense	The following table summarizes stock-based compensation expense recorded in each component of operating expenses in the Company’s condensed consolidated statements of operations for the presented periods (in thousands): Three Months Ended 2023 2022 Operations and support $ 428 $ 348 Marketing 263 251 Product development 1,098 1,390 General and administrative 2,716 2,321 Total stock-based compensation expense $ 4,505 $ 4,310

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth the computation of basic and diluted net loss per common share attributable to common stockholders (in thousands, except per share amounts): Three Months Ended 2023 2022 Numerator: Net loss $ (4,656) $ (8,146) Denominator: Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted 184,365 179,671 Net loss per share attributable to common stockholders, basic and diluted $ (0.03) $ (0.05)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following potentially dilutive shares were not included in the calculation of diluted shares outstanding for the periods presented as the effect would have been anti-dilutive (in thousands): March 31, 2023 2022 Outstanding stock options and RSUs 29,186 23,328 Sponsor earnout shares 492 492 Total 29,678 23,820

Organization and Description _2

Organization and Description of Business (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash and cash equivalents	$ 76,120	$ 58,875
Short-term investments	176,427	191,347
Long-term investments	12,118	22,463
Accumulated deficit	$ (350,017)	$ (342,305)

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Additional Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($) segment	Mar. 31, 2022 USD ($)	Dec. 31, 2022 USD ($)
Concentration Risk [Line Items]
Number of operating segments | segment	1
Number of reportable segments | segment	1
Loss on foreign currency transactions		$ 0
Accounts receivable, net	$ 70,523		$ 53,181
Payment Processors
Concentration Risk [Line Items]
Accounts receivable, net	68,200		51,100
Third Party
Concentration Risk [Line Items]
Accounts receivable, net	$ 1,800		$ 1,400

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Marketing (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Accounting Policies [Abstract]
Advertising expense	$ 7	$ 5.3

Revenue Recognition (Details)

Revenue Recognition (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($)
Contract with Customer, Liability [Roll Forward]
Beginning balance	$ 5,544
Bookings and other	46,630
Revenue recognized	(39,248)
Ending balance	$ 12,926

Investments - Schedule of Amort

Investments - Schedule of Amortized Cost and Fair Value of Available-for-sale Investments and Unrealized Gains and Losses (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Schedule Of Investments [Line Items]
Amortized Costs	$ 190,872	$ 216,730
Gross Unrealized Gains	26	0
Gross Unrealized Losses	(543)	(1,110)
Fair Value	190,355	215,620
Marketable securities:
Schedule Of Investments [Line Items]
Amortized Costs	189,062	214,920
Gross Unrealized Gains	26	0
Gross Unrealized Losses	(543)	(1,110)
Fair Value	188,545	213,810
Commercial paper
Schedule Of Investments [Line Items]
Amortized Costs	51,327	54,851
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(35)	(51)
Fair Value	51,292	54,800
Corporate securities
Schedule Of Investments [Line Items]
Amortized Costs	19,841	38,260
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(84)	(220)
Fair Value	19,757	38,040
US Government securities
Schedule Of Investments [Line Items]
Amortized Costs	103,780	108,551
Gross Unrealized Gains	9	0
Gross Unrealized Losses	(391)	(792)
Fair Value	103,398	107,759
Asset-backed securities
Schedule Of Investments [Line Items]
Amortized Costs	7,554	8,269
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(33)	(35)
Fair Value	7,521	8,234
Agency bonds
Schedule Of Investments [Line Items]
Amortized Costs	6,560	4,989
Gross Unrealized Gains	17	0
Gross Unrealized Losses	0	(12)
Fair Value	6,577	4,977
Other investments:
Schedule Of Investments [Line Items]
Amortized Costs	1,810	1,810
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Fair Value	1,810	1,810
Convertible notes
Schedule Of Investments [Line Items]
Amortized Costs	1,810	1,810
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Fair Value	$ 1,810	$ 1,810

Investments - Schedule of Contr

Investments - Schedule of Contractual Maturity of Available-for-sale Investments (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Schedule Of Investments [Line Items]
Within 1 year	$ 178,237	$ 193,157
1 to 5 years	12,118	22,463
More than 5 years	0	0
Total	190,355	215,620
Marketable securities:
Schedule Of Investments [Line Items]
Within 1 year	176,427	191,347
1 to 5 years	12,118	22,463
More than 5 years	0	0
Total	188,545	213,810
Commercial paper
Schedule Of Investments [Line Items]
Within 1 year	51,292	54,800
1 to 5 years	0	0
More than 5 years	0	0
Total	51,292	54,800
Corporate securities
Schedule Of Investments [Line Items]
Within 1 year	17,553	32,767
1 to 5 years	2,204	5,273
More than 5 years	0	0
Total	19,757	38,040
US Government securities
Schedule Of Investments [Line Items]
Within 1 year	101,005	101,289
1 to 5 years	2,393	6,470
More than 5 years	0	0
Total	103,398	107,759
Asset-backed securities
Schedule Of Investments [Line Items]
Within 1 year	0	0
1 to 5 years	7,521	8,234
More than 5 years	0	0
Total	7,521	8,234
Agency bonds
Schedule Of Investments [Line Items]
Within 1 year	6,577	2,491
1 to 5 years	0	2,486
More than 5 years	0	0
Total	6,577	4,977
Other investments:
Schedule Of Investments [Line Items]
Within 1 year	1,810	1,810
1 to 5 years	0	0
More than 5 years	0	0
Total	1,810	1,810
Convertible notes
Schedule Of Investments [Line Items]
Within 1 year	1,810	1,810
1 to 5 years	0	0
More than 5 years	0	0
Total	$ 1,810	$ 1,810

Investments - Other Investments

Investments - Other Investments (Details) - USD ($)	1 Months Ended			3 Months Ended
	Nov. 30, 2022	Sep. 30, 2022	Jul. 31, 2022	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Schedule Of Investments [Line Items]
Notes receivable from related parties				$ 1,810,000		$ 1,810,000
Loss from equity method investments				314,000	$ 0
Change in fair value of other investments				(314,000)	0
Joint Venture With Pioneer Square Labs | Corporate Joint Venture
Schedule Of Investments [Line Items]
Shares issued (in shares)			5,000,000
Ownership percentage			28%
Purchases of convertible notes	$ 500,000	$ 300,000	$ 1,000,000
Investment interest rate			5%
Notes receivable from related parties				1,800,000
Loss from equity method investments				300,000	0
Change in fair value of other investments				300,000	$ 0
Asset impairment charges				$ 0

Fair Value - Assets and Liabili

Fair Value - Assets and Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Assets
Long-term investments	$ 12,118	$ 22,463
Fair Value, Recurring
Assets
Convertible notes	1,810	1,810
Total assets measured at fair value	253,265	246,580
Fair Value, Recurring | Commercial paper
Assets
Long-term investments	51,292	54,800
Fair Value, Recurring | Corporate securities
Assets
Long-term investments	19,757	38,040
Fair Value, Recurring | US Government securities
Assets
Long-term investments	103,398	107,759
Fair Value, Recurring | Asset-backed securities
Assets
Long-term investments	7,521	8,234
Fair Value, Recurring | Agency bonds
Assets
Long-term investments	6,577	4,977
Fair Value, Recurring | Money market funds
Assets
Money market funds	56,134	23,006
Fair Value, Recurring | Commercial paper
Assets
Money market funds	6,776	7,954
Fair Value, Recurring | Level 1
Assets
Convertible notes	0	0
Total assets measured at fair value	56,134	23,006
Fair Value, Recurring | Level 1 | Commercial paper
Assets
Long-term investments	0	0
Fair Value, Recurring | Level 1 | Corporate securities
Assets
Long-term investments	0	0
Fair Value, Recurring | Level 1 | US Government securities
Assets
Long-term investments	0	0
Fair Value, Recurring | Level 1 | Asset-backed securities
Assets
Long-term investments	0	0
Fair Value, Recurring | Level 1 | Agency bonds
Assets
Long-term investments	0	0
Fair Value, Recurring | Level 1 | Money market funds
Assets
Money market funds	56,134	23,006
Fair Value, Recurring | Level 1 | Commercial paper
Assets
Money market funds	0	0
Fair Value, Recurring | Level 2
Assets
Convertible notes	0	0
Total assets measured at fair value	195,321	221,764
Fair Value, Recurring | Level 2 | Commercial paper
Assets
Long-term investments	51,292	54,800
Fair Value, Recurring | Level 2 | Corporate securities
Assets
Long-term investments	19,757	38,040
Fair Value, Recurring | Level 2 | US Government securities
Assets
Long-term investments	103,398	107,759
Fair Value, Recurring | Level 2 | Asset-backed securities
Assets
Long-term investments	7,521	8,234
Fair Value, Recurring | Level 2 | Agency bonds
Assets
Long-term investments	6,577	4,977
Fair Value, Recurring | Level 2 | Money market funds
Assets
Money market funds	0	0
Fair Value, Recurring | Level 2 | Commercial paper
Assets
Money market funds	6,776	7,954
Fair Value, Recurring | Level 3
Assets
Convertible notes	1,810	1,810
Total assets measured at fair value	1,810	1,810
Fair Value, Recurring | Level 3 | Commercial paper
Assets
Long-term investments	0	0
Fair Value, Recurring | Level 3 | Corporate securities
Assets
Long-term investments	0	0
Fair Value, Recurring | Level 3 | US Government securities
Assets
Long-term investments	0	0
Fair Value, Recurring | Level 3 | Asset-backed securities
Assets
Long-term investments	0	0
Fair Value, Recurring | Level 3 | Agency bonds
Assets
Long-term investments	0	0
Fair Value, Recurring | Level 3 | Money market funds
Assets
Money market funds	0	0
Fair Value, Recurring | Level 3 | Commercial paper
Assets
Money market funds	$ 0	$ 0

Fair Value - Level 3 Financial

Fair Value - Level 3 Financial Assets Measured at Fair Value Using Significant Unobservable Inputs (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Incremental change in fair value	$ 314
Equity Method Investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, measurement beginning balance	1,810
Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Additions during the period	0
Proportionate share of equity method losses	(314)
Fair value, measurement ending balance	$ 1,810

Fair Value - Narrative (Details

Fair Value - Narrative (Details) - USD ($)	1 Months Ended
	Jan. 31, 2022	Mar. 31, 2023	Dec. 31, 2022
Class of Stock [Line Items]
Issuance of common stock from net exercises of warrants (in shares)	2,046,220
Common stock, par value (in dollars per share)		$ 0.0001	$ 0.0001
Exercise price of warrant (in dollars per share)	$ 0.10
Number of warrants redeemed (in shares)	74,631
Derivative warrant liabilities		$ 0
Public Warrants
Class of Stock [Line Items]
Number of warrants exercised (in shares)	5,425,349
Percent of total warrants exercised	98.60%
Private Warrants
Class of Stock [Line Items]
Number of warrants exercised (in shares)	2,574,164
Percent of total warrants exercised	100%
Class A common Stock
Class of Stock [Line Items]
Issuance of common stock from net exercises of warrants (in shares)	2,046,220
Common stock, par value (in dollars per share)	$ 0.0001
Number of shares called by each warrant (in shares)	0.2558

Balance Sheet Components - Prop

Balance Sheet Components - Property and Equipment, Net (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 41,328		$ 40,914
Asset retirement obligation	225		225
Less:  Accumulated depreciation and amortization	(21,919)		(21,396)
Total property and equipment, net	19,409		19,518
Depreciation and amortization	1,000	$ 1,000
Capitalized software development costs	2,500	1,900
Internal-use software amortization	1,700	$ 1,700
Computers
Property, Plant and Equipment [Line Items]
Total property and equipment	1,413		1,452
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment	3,783		3,777
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment	13,809		13,808
Internal-use software
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 22,098		$ 21,652

Balance Sheet Components - Accr

Balance Sheet Components - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Income and other tax liabilities	$ 1,920	$ 1,670
Accrued legal expenses and open claims	862	686
Accrued legal settlements	18,000	18,000
Accrued professional services	733	435
Holdback related to business combination	1,343	1,343
Accrued share repurchase	399	0
Other current liabilities	601	560
Accrued expenses and other current liabilities	$ 23,858	$ 22,694

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Narrative (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Acquired Finite-Lived Intangible Assets [Line Items]
Goodwill impairment	$ 0	$ 0
Amortization of intangible assets	500,000	700,000
Intangible asset impairment loss	$ 0	$ 0

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Gross Book Value	$ 10,925	$ 10,983
Accumulated Amortization	(4,555)	(4,118)
Net Book Value	6,370	6,865
Pet parent relationships
Finite-Lived Intangible Assets [Line Items]
Gross Book Value	6,600	6,600
Accumulated Amortization	(3,681)	(3,478)
Net Book Value	$ 2,919	3,122
Remaining amortization period	3 years 7 months 6 days
Shelter relationships
Finite-Lived Intangible Assets [Line Items]
Gross Book Value	$ 776	834
Accumulated Amortization	(117)	(135)
Net Book Value	$ 659	699
Remaining amortization period	4 years 3 months 18 days
Technologies
Finite-Lived Intangible Assets [Line Items]
Gross Book Value	$ 1,696	1,696
Accumulated Amortization	(424)	(283)
Net Book Value	$ 1,272	1,413
Remaining amortization period	2 years 3 months 18 days
Tradenames
Finite-Lived Intangible Assets [Line Items]
Gross Book Value	$ 1,302	1,302
Accumulated Amortization	(195)	(130)
Net Book Value	$ 1,107	1,172
Remaining amortization period	4 years 3 months 18 days
Training curriculum
Finite-Lived Intangible Assets [Line Items]
Gross Book Value	$ 551	551
Accumulated Amortization	(138)	(92)
Net Book Value	$ 413	$ 459
Remaining amortization period	2 years 3 months 18 days

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Future Amortization Expense (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2023	$ 1,484
2024	1,979
2025	1,605
2026	1,094
2027	208
Thereafter	0
Net Book Value	$ 6,370	$ 6,865

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) $ in Thousands		1 Months Ended
	Oct. 20, 2022 USD ($)	Apr. 30, 2021 facility	Mar. 31, 2023 USD ($)	Dec. 31, 2022	May 31, 2022	Feb. 29, 2020
Lessee, Lease, Description [Line Items]
Sublease option to extend		1 year		1 year	1 year	2 years
Sublease income, additional base lease payments			$ 800
Number of leased facilities | facility		1
Letter of Credit | Line of Credit
Lessee, Lease, Description [Line Items]
Letter of credit			3,500
Amendment Sublease Agreement
Lessee, Lease, Description [Line Items]
Sublease income, additional base lease payments			$ 1,000
Melanie Sportsman v. A Place for Rover, Inc | Settled Litigation
Lessee, Lease, Description [Line Items]
Payment of all claims	$ 18,000
Office space | Minimum
Lessee, Lease, Description [Line Items]
Renewal term			1 year
Office space | Maximum
Lessee, Lease, Description [Line Items]
Renewal term			7 years

Commitments and Contingencies_2

Commitments and Contingencies - Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Operating lease cost	$ 981	$ 1,065
Short-term lease cost	159	0
Sublease income	(296)	(304)
Total lease cost	$ 844	$ 761

Commitments and Contingencies_3

Commitments and Contingencies - Other Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Cash paid for operating lease liabilities	$ 1,419	$ 1,153
Weighted-average discount rate	7.28%		7.27%
Weighted-average remaining lease term (years)	6 years 6 months 29 days		6 years 9 months 25 days

Commitments and Contingencies_4

Commitments and Contingencies - Lease Maturity (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Remainder of 2023	$ 3,000
2024	4,569
2025	4,693
2026	4,430
2027	4,353
Thereafter	9,430
Total lease payments	30,475
Less: imputed interest	(6,527)
Present value of lease liabilities	23,948
Less: current portion of lease liabilities	(2,478)	$ (2,727)
Total lease liabilities, noncurrent	$ 21,470	$ 22,208

Stockholders' Equity - Narrativ

Stockholders' Equity - Narrative (Details) - shares	1 Months Ended
	Jan. 31, 2022	Mar. 31, 2023
Class of Warrant or Right [Line Items]
Issuance of common stock from net exercises of warrants (in shares)	2,046,220
Number of warrants redeemed (in shares)	74,631
Warrants outstanding (in shares)		0
Public Warrant
Class of Warrant or Right [Line Items]
Number of warrants exercised (in shares)	5,425,349
Percent of total warrants exercised	98.60%
Private Warrant
Class of Warrant or Right [Line Items]
Number of warrants exercised (in shares)	2,574,164
Percent of total warrants exercised	100%

Stockholders' Equity - Share Re

Stockholders' Equity - Share Repurchase Program (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Feb. 28, 2023
Equity [Abstract]
Stock repurchase program, authorized amount			$ 50,000,000
Total number of shares purchased (in shares)	720,097	0
Average price paid per share (in dollars per share)	$ 4.22	$ 0
Total cost	$ 3,041,000	$ 0

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Jul. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding under the 2011 Plan (in shares)	13,320,000		14,363,000
Grants in period (in shares)	0	0
Aggregate intrinsic value of stock options exercised	$ 2,900,000	$ 10,000,000
Fair value of options vested	500,000	800,000
Income tax benefit related to stock-based compensation	0	0
Unrecognized compensation cost related to unvested stock options	$ 800,000
Outstanding stock options and RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in period (in shares)	8,879,000
Weighted-average remaining contractual term for unvested stock options	10 months 24 days
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested (in shares)	(492,000)
Weighted-average remaining contractual term for unvested stock options	3 years 2 months 12 days
Unrecognized compensation cost related to RSUs	$ 73,400,000
Fair value of RSUs vested	$ 3,500,000	$ 2,500,000
2021 Plan | Share-based Payment Arrangement
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares initially reserved for issuance (in shares)	8,600,000			17,200,000
2011 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding under the 2011 Plan (in shares)				20,400,000

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of stock option activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Equity Available for Grant
Equity awards granted (in shares)	0	0
Equity awards cancelled and forfeited (in shares)	4,000
Number of Options Outstanding
Balance as of beginning of period (in shares)	14,363,000
Options exercised (in shares)	(1,039,000)
Options cancelled and forfeited (in shares)	(4,000)
Balance as of end of period (in shares)	13,320,000		14,363,000
Number of options vested and exercisable (in shares)	12,456,000
Weighted- Average Exercise Price Per Share
Outstanding options at period start (in dollars per share)	$ 1.71
Options exercised (in dollars per share)	1.45
Options cancelled and forfeited (in dollars per share)	2.72
Outstanding options at period end (in dollars per share)	1.73		$ 1.71
Weighted average exercise price of options vested and exercisable (in dollars per share)	$ 1.70
Weighted- Average Remaining Contractual Term (Years)
Weighted average remaining contractual term of options outstanding	4 years 9 months 18 days		4 years 10 months 24 days
Weighted average remaining contractual term of options vested and exercisable	4 years 7 months 6 days
Aggregate Intrinsic Value
Aggregate intrinsic value of options outstanding	$ 37,343		$ 28,251
Aggregate intrinsic value of options vested and exercisable	$ 35,218
Outstanding stock options and RSUs
Equity Available for Grant
Balance as of beginning of period (in shares)	7,881,000
Equity awards authorized (in shares)	9,226,000
Equity awards granted (in shares)	(8,879,000)
Equity awards cancelled and forfeited (in shares)	147,000
Equity awards withheld under net share settlement (in shares)	184,000
Balance as of end of period (in shares)	8,559,000		7,881,000
Number of Options Outstanding
Options cancelled and forfeited (in shares)	(147,000)

Stock-Based Compensation - Rest

Stock-Based Compensation - Restricted Stock Units (Details) - Restricted Stock Units (RSUs) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	4 years
Number of Shares
Unvested, beginning of period (in shares)	7,622,000
Grants (in shares)	8,879,000
Vested (in shares)	(492,000)
Forfeited (in shares)	(143,000)
Unvested, end of period (in shares)	15,866,000
Weighted- Average Grant Date Fair Value
Unvested beginning of period (in dollars per share)	$ 6.22
Granted (in dollars per share)	3.85
Vested (in dollars per share)	7.15
Forfeited (in dollars per share)	6.17
Unvested end of period (in dollars per share)	$ 4.86
Aggregate Intrinsic Value
Unvested aggregate intrinsic value	$ 71,877		$ 27,975
Equity awards withheld under net share settlement (in shares)	183,674
Fair value of RSUs vested	$ 3,500	$ 2,500

Stock-Based Compensation - Sc_2

Stock-Based Compensation - Schedule of stock-based compensation expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 4,505	$ 4,310
Operations and support
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	428	348
Marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	263	251
Product development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	1,098	1,390
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 2,716	$ 2,321

Income Taxes (Details)

Income Taxes (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Effective tax rate	0%	(0.10%)
Increase in unrecognized tax benefits	$ 38,500,000
Unrecognized tax benefits that would impact effective tax rate	$ 0

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - EPS (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Earnings Per Share [Abstract]
Net loss	$ (4,656)	$ (8,146)
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	184,365	179,671
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	184,365	179,671
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.03)	$ (0.05)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.03)	$ (0.05)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Antidilutive (Details) - shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	29,678,000	23,820,000
Outstanding stock options and RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	29,186,000	23,328,000
Sponsor earnout shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	492,326	492,000
Rover Earnout Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	2,192,687

Net Loss Per Share Attributab_5

Net Loss Per Share Attributable to Common Stockholders - Narrative (Details)	3 Months Ended
	Mar. 31, 2023 d $ / shares shares	Mar. 31, 2022 shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	29,678,000	23,820,000
Sponsor earnout shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Earnout period, stock price trigger | $ / shares	$ 16
Earnout period, threshold trading days | d	20
Earnout period, threshold consecutive trading day | d	30
Sponsor earnout shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	492,326	492,000
Rover Earnout Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	2,192,687

Subsequent Events (Details)

Subsequent Events (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended
	May 09, 2023	Mar. 31, 2023	Mar. 31, 2022
Subsequent Event [Line Items]
Total number of shares purchased (in shares)		720,097	0
Total cost		$ 3,041	$ 0
Average price paid per share (in dollars per share)		$ 4.22	$ 0
Subsequent Event
Subsequent Event [Line Items]
Total number of shares purchased (in shares)	990,498
Total cost	$ 4,300
Average price paid per share (in dollars per share)	$ 4.38